Scott Akamine serves as Executive at Cerevel Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Scott Akamine has executed 9 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 1, 2024 involved selling 7,527 shares valued at $0.
Scott Akamine currently holds 7,237 shares of Cerevel Therapeutics Holdings, Inc. (CERE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Akamine has been a net seller of CERE stock. They have purchased $0 and sold $1.4M worth of shares.
Scott Akamine's most recent insider trade was on Aug 1, 2024, when they sold 7,527 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $41.42 |
| Discretionary |
| Dec 19, 2023 | CERE | $0 | Option Exercise | 13,796 | $N/A | Discretionary |
| Dec 7, 2023 | CERE | $413.7K | Sale | 10,000 | $41.37 | Planned |
| Dec 7, 2023 | CERE | $131.7K | Option Exercise | 10,000 | $13.17 | Planned |
| Dec 5, 2023 | CERE | $262.5K | Sale | 7,500 | $35.00 | Planned |
| Dec 5, 2023 | CERE | $98.8K | Option Exercise | 7,500 | $13.17 | Planned |
| Aug 8, 2022 | CERE | $131.7K | Option Exercise | 10,000 | $13.17 | Discretionary |
| Aug 8, 2022 | CERE | $400.0K | Sale | 10,000 | $40.00 | Discretionary |